Document is current
Any future updates will be listed below
-
Authors
Kadam, Esha http://orcid.org/0000-0002-8739-4502
Javaid, Mahnoor http://orcid.org/0000-0002-1501-1031
Sen, Parikshit http://orcid.org/0000-0002-1630-6026
Saha, Sreoshy http://orcid.org/0000-0001-6745-9770
Ziade, Nelly http://orcid.org/0000-0002-4479-7678
Day, Jessica http://orcid.org/0000-0001-8528-4361
Wincup, Chris http://orcid.org/0000-0002-8742-8311
Andreoli, Laura http://orcid.org/0000-0002-9107-3218
Parodis, Ioannis http://orcid.org/0000-0002-4875-5395
Tan, Ai Lyn http://orcid.org/0000-0002-9158-7243
Shinjo, Samuel Katsuyuki http://orcid.org/0000-0002-3682-4517
Dey, Dzifa http://orcid.org/0000-0002-3339-5112
Cavagna, Lorenzo http://orcid.org/0000-0003-3292-1528
Chatterjee, Tulika http://orcid.org/0000-0001-8844-851X
Knitza, Johannes http://orcid.org/0000-0001-9695-0657
Wang, Guochun http://orcid.org/0000-0002-4616-9376
Dalbeth, Nicola http://orcid.org/0000-0003-4632-4476
Velikova, Tsvetelina http://orcid.org/0000-0002-0593-1272
Battista, Simone http://orcid.org/0000-0002-7471-1951
Cheng, Karen http://orcid.org/0009-0004-3850-8480
Boyd, Peter http://orcid.org/0009-0009-4753-8717
Kobert, Linda http://orcid.org/0000-0002-3374-1003
Gracia-Ramos, Abraham Edgar http://orcid.org/0000-0003-1842-2554
Mittal, Srijan
Makol, Ashima http://orcid.org/0000-0002-8748-898X
Gutiérrez, Carlos Enrique Toro http://orcid.org/0000-0002-6084-7049
Uribe, Carlo V Caballero http://orcid.org/0000-0002-9845-8620
Kuwana, Masataka http://orcid.org/0000-0001-8352-6136
Burmester, Gerd-Rüdiger http://orcid.org/0000-0001-7518-1131
Guillemin, Francis http://orcid.org/0000-0002-9860-7024
Nikiphorou, Elena http://orcid.org/0000-0001-6847-3726
Chinoy, Hector http://orcid.org/0000-0001-6492-1288
Aggarwal, Vikas http://orcid.org/0000-0002-2089-027X
Gupta, Latika http://orcid.org/0000-0003-2753-2990
,
- License Information
-
More Information
Article History
Received: 13 November 2023
Accepted: 21 February 2024
First Online: 12 April 2024
Declarations
:
: ALT has received honoraria for advisory boards and speaking for Abbvie, Gilead, Janssen, Lilly, Novartis, Pfizer, and UCB. EN has received speaker honoraria/participated in advisory boards for Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie, and Lilly, and holds research grants from Pfizer and Lilly. HC has received consulting fees as a speaker for GSK, UCB; Advisory Board member for Astra Zeneca, Pfizer, Argenx, Galapagos; Data and Science Monitoring Board chair for Horizon Therapeutics. IP has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis and F. Hoffmann-La Roche AG. JD has received research funding from CSL Limited. KC is the lead at the European Patient Advocacy Group (ePAG) and a patient with myositis. LK works at The Myositis Association which receives support from Octapharma, Mallinckrodt, Pfizer, argenx, Alexion, Janssen, Abcuro, Priovant, Horizon, and EMD Serono. MK has received speaker honoraria/participated in advisory boards for Asahi-Kasei, AstraZeneca, Boehringer-Ingelheim, Chugai, isai, GSK, Kissei, BML, Mochida, Nippon Shinyaku, Ono Pharmaceuticals, and Tanabe-Mitsubishi. ND has received consulting fees, speaker fees or grants from AstraZeneca, Novartis, Horizon, Selecta, Arthrosi, JW Pharmaceutical Corporation, PK Med, LG Chem, JPI, PTC Therapeutics, Protalix, Unlocked Labs, Hikma, Dexoligo Therapeutics. NZ has received speaker fees, advisory board fees, and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen, and Pierre Fabre; none are related to this manuscript. TV has received speaker honoraria from Pfizer and AstraZeneca, non-related to the current manuscript. The rest of the authors have no conflict of interest relevant to this manuscript.
: The ethical approval has been obtained from the Institutional Ethics Committee at the SGPGIMS, Raebareli Road, Lucknow, India, postal code 226014.
